Atara Biotherapeutics, Inc. is a biotechnology company based in California that develops cell therapies. According to its filing, it lobbied on health issues, specifically matters related to regulation of cell therapies. The company used a hired firm to engage on these regulatory topics, and its most recent disclosure was filed on April 3, 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRETT MEEKS
The latest disclosures for this client.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
Q2JEFFREY J. KIMBELL & ASSOCIATES, INC.
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
DAVID RUDLOFF
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN HERZOG
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN R RAY
JEFFREY J. KIMBELL & ASSOCIATES, INC.
KEITH STUDDARD
JEFFREY J. KIMBELL & ASSOCIATES, INC.
LAURA KEMPER
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr JEFFREY J KIMBELL
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr KENNETH LEE HODGE
JEFFREY J. KIMBELL & ASSOCIATES, INC.